PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 1988Heart16 citationsOpen Access

Thrombin and plasmin activity in coronary artery disease.

MSMichael SmallGLG.D.O. LoweJDJ.T. Douglas

Structured PICO

Is angiographically defined coronary artery disease associated with altered basal plasmin and thrombin activity compared to healthy controls?

P
Population
131 men, comprising 98 with angiographically defined coronary artery disease and 33 healthy controls
C
Comparator
Healthy controls (n=33)
O
Outcome
Basal plasmin and thrombin activity in plasma (assessed by radioimmunoassay of fibrinogen derivatives B beta 15-42 and fibrinopeptide A)surrogate

The presence of enhanced thrombin activity (elevated fibrinopeptide A) in men with coronary artery disease supports an association between coronary artery disease and a hypercoagulable state.

Abstract

Basal plasmin and thrombin activity in plasma were assessed by radioimmunoassay of the fibrinogen derivatives containing the sequence B beta 15-42 and of fibrinopeptide A respectively in a cross sectional controlled study of men with coronary artery disease. Compared with healthy controls (n = 33) men with angiographically defined coronary artery disease (n = 98) had a modest but significant increase in concentrations of fibrinopeptide A, indicating an activated coagulation system. Concentrations of B beta 15-42 were similar in those with coronary artery disease and in the controls. The enhanced thrombin activity in coronary artery disease is in keeping with current evidence suggesting an association between coronary artery disease and a hypercoagulable state.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Small et al. (1988) studied this question.

synapsesocial.com/papers/6a23b1bbc1f1c7a6bca0603ehttps://doi.org/10.1136/hrt.60.3.201
Ask AI
Helpful
Bookmark
Share
View Full Paper